Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Work In Process (2016 - 2021)

Guided Therapeutics' Work In Process history spans 8 years, with the latest figure at $80000.0 for Q1 2021.

  • On a quarterly basis, Work In Process fell 1.23% to $80000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $80000.0, a 1.23% decrease, with the full-year FY2020 number at $80000.0, down 1.23% from a year prior.
  • Work In Process hit $80000.0 in Q1 2021 for Guided Therapeutics, roughly flat from $80000.0 in the prior quarter.
  • Over the last five years, Work In Process for GTHP hit a ceiling of $115000.0 in Q1 2017 and a floor of $80000.0 in Q3 2020.
  • Historically, Work In Process has averaged $85000.0 across 5 years, with a median of $81000.0 in 2018.
  • Biggest five-year swings in Work In Process: plummeted 69.37% in 2017 and later changed 0.0% in 2019.
  • Tracing GTHP's Work In Process over 5 years: stood at $82000.0 in 2017, then dropped by 1.22% to $81000.0 in 2018, then changed by 0.0% to $81000.0 in 2019, then decreased by 1.23% to $80000.0 in 2020, then changed by 0.0% to $80000.0 in 2021.
  • Business Quant data shows Work In Process for GTHP at $80000.0 in Q1 2021, $80000.0 in Q4 2020, and $80000.0 in Q3 2020.